Supply Chain

Hospitals nationwide are experiencing medical supply shortages caused by lower production levels in Puerto Rico, which produces nearly 10 percent of the U.S.'s drugs, reports The New York Times.

The Food and Drug Administration on Monday launched an educational campaign to ensure healthcare providers are well informed about biosimilars, according to an agency blog post.

A woman said she was walking her dog when they came upon a pile of "hundreds" of medical supplies strewn across the ground near Baylor University Medical Center at Dallas, Fox-4 News reports.

The FDA issued a warning letter to North Billerica, Mass.-based Magellan Diagnostics after an inspection found the company violated several federal laws with the manufacturing and marketing of its blood-lead testing system.

The FDA granted breakthrough therapy designation to Novartis' melanoma treatment, a combination of its Tafinlar and Mekinist drugs.

GlaxoSmithKline on Friday earned Food and Drug Administration approval for its shingles vaccine Shingrix.

Here are seven drug and medical device companies that made headlines in the past week.

Merck on Friday announced plans to cut 1,800 sales positions in the U.S., reports Reuters.

Introducing biosimilar versions of complex drugs into the marketplace could cut U.S. healthcare spending by $54 billion over the next 10 years, according to an analysis conducted by the RAND Corp.

The FDA isn't doing enough to regulate health and wellness mobile apps, which are becoming increasingly popular for developers and the general population, medical media expert at Houston-based Rice University Kirsten Ostherr, PhD, told Science Daily.